Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone
- 1 April 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (7) , 1009-1012
- https://doi.org/10.1016/s0960-894x(99)00119-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-oneBioorganic & Medicinal Chemistry Letters, 1999
- Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)Journal of Medicinal Chemistry, 1999
- New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinoneBioorganic & Medicinal Chemistry Letters, 1998
- Discovery of Nonsteroidal AndrogensBiochemical and Biophysical Research Communications, 1998
- Synthesis and Biological Activity of a Novel Series of Nonsteroidal, Peripherally Selective Androgen Receptor Antagonists Derived from 1,2-Dihydropyridono[5,6-g]quinolinesJournal of Medicinal Chemistry, 1998
- Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trialUrology, 1997
- Reversal of activity profile in analogs of the antiprogestin RU 486: Effect of a 16α-substituent on progestational (agonist) activityLife Sciences, 1993
- Novel steroidal pure antiestrogensSteroids, 1989
- Reactions of β-Keto Esters with Aromatic Amines. Syntheses of 2- and 4-Hydroxyquinoline Derivatives1Journal of the American Chemical Society, 1948